The Role of T&K in Stroke Ombolysis

The Nordtens2 trial found an unacceptable rate of ICH and death associated with a 0.4 milligram per kilogram dose of T&K when compared to altiplastin. With the goal to decrease rates of ICH, interest rate for hemorrhage and systemic bleeding complications, the safety of T &K thrombolysis is still being evaluated. The comparative effectiveness of routine tenectoplase versus altiplast in acute ischemic stroke or certain trial accumulated an incredible amount of data from 25 international stroke networks.